Brown Advisory’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.9M | Sell |
995,299
-91,001
| -8% | -$3.01M | 0.04% | 250 |
|
|
2025
Q1 | $43.7M | Buy |
1,086,300
+9,869
| +0.9% | +$397K | 0.06% | 204 |
|
|
2024
Q4 | $50.6M | Sell |
1,076,431
-89,560
| -8% | -$4.21M | 0.06% | 205 |
|
|
2024
Q3 | $61.6M | Buy |
1,165,991
+403,442
| +53% | +$21.3M | 0.08% | 184 |
|
|
2024
Q2 | $41.3M | Buy |
762,549
+3,015
| +0.4% | +$163K | 0.05% | 235 |
|
|
2024
Q1 | $53.3M | Buy |
+759,534
| New | +$53.3M | 0.07% | 200 |
|
|
2022
Q1 | – | Sell |
-11,759
| Closed | -$536K | – | 1148 |
|
|
2021
Q4 | $536K | Buy |
+11,759
| New | +$536K | ﹤0.01% | 855 |
|